Microdermis Corporation, a life sciences company with an innovative delivery platform, focuses on the development of novel drug, device and healthcare products that combine known, proven active ingredients with its unique Amidermal delivery system to produce compelling products with significantly-enhanced performance, low manufacturing costs, and rapid time-to-market. With a pipeline products in commercial development, Microdermis actively targets both military and civilian applications of its technologies, both in the US and abroad. ProvodineMicrodermis initial commercial productis a next-generation professional antiseptic that meets or exceeds FDA requirements for use as a Surgical Scrub, Pre-Operative Skin Preparation, Healthcare Personnel Hand Wash and First Aid Antiseptic. Microdermis unique Amidermal technology enables significantly enhanced kill strength, killing the most dangerous microbes. There are currently no known resistant strains to Provodine, making it especially useful for deployment in challenging environments with an unknown mix of infection sources, such as in military field hospitals and with globally-deployed NGO personnel. The Amidermal technology also extends the potency window of the active ingredient, with persistence exceeding 6 hours. All of this remarkable antimicrobial performance comes in a surprisingly skin-friendly lotion. Provodine contains a proprietary blend of ingredients that nourish and rebuild the skin, eliminating dryness and cracking, which are not only uncomfortable, but also create portals for microbes. Healthy skin leads to better compliance with hand hygiene protocols.